Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

about

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

Item

http://www.wikidata.org/entity/Q35840277

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@ast

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@en

type

Item

label

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@ast

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@en

prefLabel

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@ast

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@en

P1476

Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

@en

P2093

E Güler

http://www.w3.org/2001/XMLSchema#string

F B Güragaç

http://www.w3.org/2001/XMLSchema#string

T K Akyüz

http://www.w3.org/2001/XMLSchema#string

Y Totan

http://www.w3.org/2001/XMLSchema#string

P2860

The multifunctional choroid

Intraocular pressure measurements using dynamic contour tonometry after laser in situ keratomileusis.

Noninvasive investigations of the normal ocular circulation in humans.

Foveolar choroidal hemodynamics in proliferative diabetic retinopathy.

Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography.

Managing diabetic macular edema: The leading cause of diabetes blindness

Comparison of dynamic contour tonometry with goldmann applanation tonometry.

Dynamic contour tonometry in comparison to intracameral IOP measurements.

Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

P2888

eye.2015.232

P304

369-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2015.232

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26563658

http://www.w3.org/2001/XMLSchema#string

P932

4791693

http://www.w3.org/2001/XMLSchema#string